<DOC>
	<DOCNO>NCT01116401</DOCNO>
	<brief_summary>We plan enroll 60 healthy , non-pregnant premenopausal woman age 18-45 hot flash ( order 30 woman complete study procedure ) trial investigate impact hot flash develop response injection GnRH agonist , leuprolide ( brand name : Lupron ) sleep disruption mood . This study design mimic menopause transition . Based previous study , expect 2/3 woman develop hot flash , naturally divide participant two group : + hot flash hot flash . We collect data sleep disruption mood change compare difference + hot flash group group woman develop hot flash leuprolide . Specific Aim 1 : To determine effect hot flash sleep use model induce hot flash pre-menopausal woman . Hypothesis 1a : Hot flash worsen objectively measure sleep Hypothesis 1b : Exposure hot flash lead perception poor sleep quality Specific Aim 2 : To identify relative effect hot flash sleep disruption mood use model induce hot flash premenopausal woman . Hypothesis 2a : Objectively measure sleep disturbance great effect hot flash mood Hypothesis 2b : Perception poor sleep correlate negative mood Exploratory Aim : To establish feasibility identify specific genetic polymorphism gene involve estrogen pathway development hot flash .</brief_summary>
	<brief_title>Impact Hot Flashes Sleep Mood Disturbance</brief_title>
	<detailed_description />
	<mesh_term>Hot Flashes</mesh_term>
	<mesh_term>Leuprolide</mesh_term>
	<mesh_term>Deslorelin</mesh_term>
	<criteria>Women 1845 year old Premenopausal , define regular monthly menstrual cycle ( every 2535days ) past 6 month corroborate midluteal phase progesterone &gt; 3 ng/ml Willingness use barrier method contraception study completion study menses resume Good general health normal hemoglobin , prolactin , TSH , liver function test ( SGOT , SGPT , bilirubin ) renal function test ( BUN , creatinine , alkaline phosphatase ) Pregnancy , determine serum HCG screen visit immediately precede ( day day ) GnRH agonist administration , currently breastfeed . Hot flush , determine subjectively ( 7day hot flash diary ) objectively ( 24hour skinconductance monitoring Midluteal phase progesterone &lt; 3ng/mL Clinically significant abnormality screen blood test . BMI &gt; 35 kg/m2 Previously diagnose osteoporosis osteopenia Clinically significant depressive symptom ( MontgomeryAsberg Depression Rating Scale ( MADRS ) score &gt; 10 ) Psychiatric illness , define clinical interview MiniInternational Neuropsychiatric Interview ( MINI ) . Sleep apnea periodic limb movement sleep ( PLMS ) either diagnose previously screen polysomnography ( PSG ) study . Contraindication , hypersensitivity , previous allergic reaction GnRH agonists Current recent ( one month ) use centrally active medication ( antidepressant , anxiolytic , hypnotic , anticonvulsant gabapentin . Current recent ( 3 month ) use systemic hormone medication Night shift worker Current recent ( one month ) overthecounter ( OTC ) medication may affect hot flash , sleep , mood ( eg diphenhydramine , St. John 's Wort , Black Cohosh , phytoestrogen supplement ) Abnormal vaginal bleeding History medical disease may put subject risk treat study medication . These include history thromboembolism cardiovascular disease , congestive heart failure condition require sodium restriction , spinal cord compression , metastatic vertebral lesion , memory disorder , urinary tract obstruction history liver , kidney , pulmonary , metabolic disease may put subject risk treat study medication .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Hot Flashes</keyword>
	<keyword>Sleep disturbance</keyword>
	<keyword>Lupron</keyword>
	<keyword>Menopause</keyword>
</DOC>